Saturday 17 October 2026 Export CNTB’s income statement to Excel — free account

Connect Biopharma Holdings Limited Sponsored ADR

Connect Biopharma Holdings Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $64,000.00, down 99.8% from fiscal 2024. In the quarter to June 2026, revenue grew 296.6%, EPS fell 17.4%, free cash flow fell 23.5% and total debt fell 61.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.91 0.00 0.00%

Follow CNTB

Alert me

Market cap: $57.1M
P/E: 0.0×
Fwd P/E: −2.0×
Dividend yield: —
F-score: n/a
Altman Z: −5.94
Beneish M: 681.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	—	0.00	0.00
P/S ratio Full definition →		42.47	—	159.13	49.87
P/FCF ratio Full definition →		0.00	—	0.00	0.00
P/Operating CF Full definition →		(4.83)	—	(9.26)	(9.40)
P/B ratio Full definition →		1.52	—	3.48	5.57
Price to Tangible BV Full definition →		1.52	—	3.48	5.58
EV/Sales Full definition →		15.04	—	109.99	39.45
EV/EBITDA Full definition →		0.00	—	0.00	0.00
EV/Operating CF Full definition →		(0.70)	—	(1.79)	(1.95)
EV/FCF Full definition →		(0.69)	—	(1.78)	(1.94)
Quick Ratio Full definition →		5.48	3.74	3.23	2.37
Current Ratio Full definition →		5.48	3.74	3.23	2.37
Net Debt/EBITDA Full definition →		3.11	2.87	2.35	1.79
Debt/Assets Full definition →		0.66%	0.66%	0.48%	0.47%
Debt/Equity Full definition →		0.01	0.01	0.01	0.01
Asset Turnover Full definition →		0.02	0.00	0.01	0.05
Operating CF/Net income Full definition →		1.01	0.74	0.83	0.92
Capex/Depreciation Full definition →		(0.19)	(0.09)	0.00	0.00
Research and Development Expense of Revenue Full definition →		69,437.50%	0.00%	8,893.49%	587.90%
Selling, General and Administrative Expense of Revenue Full definition →		41,143.75%	0.00%	2,808.28%	148.09%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		5,725.00%	0.00%	709.47%	45.56%
Graham Net Nets Full definition →		0.60	—	0.25	0.15
Graham Number Full definition →		0.00	—	0.00	0.00
Earnings Yield Full definition →		(59.03%)	—	(43.89%)	(50.00%)
Free Cash Flow Yield Full definition →		(51.12%)	—	(38.94%)	(40.77%)
Revenue per Share Full definition →		0.00	0.00	0.00	0.04
Operating CF per Share Full definition →		(0.31)	(0.20)	(0.28)	(0.25)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.31)	(0.20)	(0.28)	(0.25)
Cash per Share Full definition →		0.98	0.80	0.81	0.50
Shareholders Equity per Share Full definition →		0.99	0.75	0.75	0.43
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.99	0.75	0.75	0.43
Free Cash Flow Full definition →		(17.44)	(11.27)	(16.00)	(15.92)
Working Capital Full definition →		51.17	37.32	37.98	22.32
Capital Expenditures Full definition →		(0.03)	(0.02)	—	—
Net Current Asset Value Full definition →		50.61	36.83	37.58	22.01
EV/EBIT Full definition →		0.00	—	0.00	0.00
Capex to Sales Full definition →		2.13	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	—	0.00	0.00
Other line items
Average Receivables Full definition →		4.99	4.92	6.37	6.56
Average Payables Full definition →		3.85	1.15	2.56	2.16
Average Assets Full definition →		93.97	78.68	76.38	63.10
Average Common Equity Full definition →		82.93	67.07	62.76	49.10

Fold the line items

Columns are period end dates

Stockrow Weekly